APA (7th ed.) Citation

Woelfel, S., Dütschler, J., Junker, D., König, M., Graf, N., Krieger, C., . . . Misselwitz, B. (2025). XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease. Alimentary Pharmacology & Therapeutics, 61(2), 299. https://doi.org/10.1111/apt.18349

Chicago Style (17th ed.) Citation

Woelfel, Simon, et al. "XBB.1.5‐Adapted COVID‐19 MRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics 61, no. 2 (2025): 299. https://doi.org/10.1111/apt.18349.

MLA (9th ed.) Citation

Woelfel, Simon, et al. "XBB.1.5‐Adapted COVID‐19 MRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease." Alimentary Pharmacology & Therapeutics, vol. 61, no. 2, 2025, p. 299, https://doi.org/10.1111/apt.18349.